Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2015 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SESEN BIO, INC. | 13 | Q4 2020 | 100.0% |
RHYTHM PHARMACEUTICALS, INC. | 8 | Q3 2019 | 80.0% |
CONSTELLATION PHARMACEUTICALS INC. | 8 | Q2 2020 | 96.6% |
ZAFGEN, INC. | 7 | Q2 2019 | 2.0% |
KALA PHARMACEUTICALS INC. | 3 | Q2 2018 | 18.6% |
SESEN BIO, INC. | 2 | Q2 2021 | 100.0% |
CYTOMX THERAPEUTICS, INC. | 2 | Q1 2018 | 31.7% |
0 | 1 | Q3 2021 | 0.0% |
View TRV GP, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-05 |
13F-HR | 2021-08-11 |
13F-HR | 2021-05-12 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-06 |
13F-HR | 2020-08-07 |
13F-HR | 2020-05-11 |
13F-HR | 2020-02-05 |
13F-HR | 2019-11-04 |
13F-HR | 2019-08-06 |
View TRV GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.